A man in his 60s who developed capillary leak syndrome after receiving the AstraZeneca COVID-19 vaccine has been awarded NT$400,000 (US$12,509) in compensation by the government's Vaccine Injury Compensation Program (VICP).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares open lower
09/10/2026 09:15 AM - Politics
Lai welcomes new Palau envoy, thanks ally for int'l support
09/09/2026 08:47 PM - Society
MOL warns foodpanda over docking couriers' pay for late deliveries
09/09/2026 08:26 PM - Business
TSMC's market share hits record 72.5% in Q2
09/09/2026 08:15 PM - Politics
Taiwan, U.S. must counter China gray-zone pressure: Stanford scholar
09/09/2026 07:50 PM